EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Novel Matrix Metalloproteinase-9 (MMP-9) Inhibitors in Cancer Treatment

Zainab Ahmed Rashid, Sanaa K Bardaweel iD

International Journal of Molecular Sciences · 28.07.2023 · 24 (15) · 12133

DOI: 10.3390/ijms241512133 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 28.07.2023. Verfasst von Zainab Ahmed Rashid und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, School of Pharmacy, University of Jordan, Amman 11942, Jordan. Hauptthemen laut MEDLINE: Matrix Metalloproteinase 9, Neoplasms. Die Arbeit wurde bisher 113-mal zitiert (Crossref) und nennt 166 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Matrix metalloproteinases (MMPs) belong to a family of zinc-dependent proteolytic metalloenzymes. MMP-9, a member of the gelatinase B family, is characterized as one of the most intricate MMPs. The crucial involvement of MMP-9 in extracellular matrix (ECM) remodeling underscores its significant correlation with each stage of cancer pathogenesis and progression. The design and synthesis of MMP-9 inhibitors is a potentially attractive research area. Unfortunately, to date, there is no effective MMP-9 inhibitor that passes the clinical trials and is approved by the FDA. This review primarily focuses on exploring the diverse strategies employed in the design and advancement of MMP-9 inhibitors, along with their anticancer effects and selectivity. To illuminate the essential structural characteristics necessary for the future design of novel MMP-9 inhibitors, the current narrative review highlights several recently discovered MMP-9 inhibitors exhibiting notable selectivity and potency.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Matrix Metalloproteinase 9NeoplasmsHumansMatrix Metalloproteinase InhibitorsMatrix MetalloproteinasesProteolysisExtracellular Matrix

Stichwörter der Autor:innen

MMP-9anticancerinhibitorsmatrix metalloproteinasemolecular docking

Substanzen

Matrix Metalloproteinase 9Matrix Metalloproteinase InhibitorsMatrix Metalloproteinases

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, School of Pharmacy, University of Jordan, Amman 11942, Jordan.

ORCID-Profile: Sanaa K Bardaweel

Zitieren

APA

Rashid, Z. A., & Bardaweel, S. K. (2023). Novel Matrix Metalloproteinase-9 (MMP-9) Inhibitors in Cancer Treatment. International Journal of Molecular Sciences, 24(15), 12133. https://doi.org/10.3390/ijms241512133

Vancouver

Rashid ZA, Bardaweel SK. Novel Matrix Metalloproteinase-9 (MMP-9) Inhibitors in Cancer Treatment. International Journal of Molecular Sciences. 2023;24(15):12133. doi:10.3390/ijms241512133

BibTeX
@article{Rashid2023,
  author = {Rashid, Zainab Ahmed and Bardaweel, Sanaa K},
  title = {Novel Matrix Metalloproteinase-9 (MMP-9) Inhibitors in Cancer Treatment},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {15},
  pages = {12133},
  doi = {10.3390/ijms241512133}
}
Kostenlos starten →